Discovery of podophyllotoxins (Q42541938)

2 November 2017

title

Discovery of podophyllotoxins (English)

1 reference

2 November 2017

Imbert TF

1

1 reference

2 November 2017

publication date

1 March 1998

1 reference

2 November 2017

1 reference

2 November 2017

volume

80

1 reference

2 November 2017

issue

3

1 reference

2 November 2017

page(s)

207-222

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

2 November 2017

1 reference

7 January 2021

Tumour-inhibitory aryltetralin lignans from Podophyllum pleianthum

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Indian Podophyllum: Is It Podophyllum emodi or Podophyllum hexandrum?

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Cytotoxic Agents of Thujopsis dolabrata (L. fil.) SIEB. et ZUCC

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Potential anticancer agents II: antitumor and cytotoxic lignans from Linum album (Linaceae)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Cytotoxic and tumor inhibitory agent from Polygala macradenia Gray (Polygalaceae): 4'-demethyldeoxypodophyllotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Biosynthetic relationship of aryltetralin lactone lignans to dibenzylbutyrolactone lignans

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Biosynthesis of podophyllum lignans—i. cinnamic acid precursors of podophyllotoxin in podophyllum hexandrum

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Biosynthesis of Podophyllum lignans—II. Interconversions of aryltetralin lignans in Podophyllum hexandrum

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Steganacin and steganangin, novel antileukemic lignan lactones from Steganotaenia araliacea.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Podophyllotoxin, steganacin and combretastatin: natural products that bind at the colchicine site of tubulin

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

The podophyllotoxin-picropodophyllin equilibrium

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Synthesis of Podophyllotoxin1,2

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Dehydropodophyllotoxin, a New Compound Isolated from Podophyllum peltatum L.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

The Cytological Effects of Podophyllin

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Effects of resin of podophyllum on normal skin, condylomata acuminata and verrucae vulgares

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

The Biochemical Events of Mitosis. II. The in Vivo and in Vitro Binding of Colchicine in Grasshopper Embryos and Its Possible Relation to Inhibition of Mitosis*

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

The separation of acyl protection groups in alkali-sensitive glucosides. Synthesis of podophyllotoxin-beta-D-glucoside

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Concerning a new glycoside preparation method. Synthesis of epidopodophyllotoxin-beta-D-glucopyranoside

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

On a new glycoside synthesis process. II. Glycosides of 4'-demethylepipodophyllotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

[Partial synthesis of 4'-demethylepipodophyllotoxin]

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Chemistry and mode of action of podophyllin derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Synthesis and antimitotic activity of glycosidic lignan derivatives related to podophyllotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Effects of podophyllotoxin and VP-16-213 on microtubule assembly in vitro and nucleoside transport in HeLa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Effect of VP-16-213 on the intracellular degradation of DNA in HeLa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Protein-associated DNA breaks in cells treated with adriamycin or ellipticine

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Qualitative and quantitative aspects of intercalator-induced DNA strand breaks

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Relationship between cytotoxicity and dna strand break-age produced by adriamycin and other intercalating agents

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

VP16-213 and podophyllotoxin. A study on the relationship between chemical structure and biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Characterization of VP-16-induced DNA damage in isolated nuclei from L1210 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM26: a quantitative structure-activity relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Inhibition of the DNA catenation activity of type II topoisomerase by VP16-213 and VM26

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Peroxidative free radical formation and O-demethylation of etoposide(VP-16) and teniposide(VM-26)

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Microsomal interactions and inhibition of lipid peroxidation by etoposide (VP-16, 213): implications for mode of action

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Iron-dependent hydroxyl radical formation and DNA damage from a novel metabolite of the clinically active antitumor drug VP-16.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Experience with 4'-demethylepipodo-phyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside); VM-26; NSC-122819 in the treatment of malignant lymphosis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Chemotherapy versus chemoimmunotherapy for small-cell undifferentiated carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Etoposide (VP-16-213). Current status of an active anticancer drug

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Etoposide as a single agent in relapsed advanced lymphomas. A phase II study.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Study on conformations--biological activities relationships for podophyllotoxin analogues based on crystal structure of deoxypodophyllotoxin (anthricin).

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Structure-activity relationships of VP-16 analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

The mechanisms of DNA topoisomerases

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

The clinical pharmacology of etoposide: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

DNA topoisomerase I and II in cancer chemotherapy: update and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Differential patterns of anti-tumour drug responses and mechanisms of resistance in a series of independently-derived VP-16-resistant human tumour cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Clinical and pharmacokinetic overview of parenteral etoposide phosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Studies on lignan lactone antitumor agents. II. Synthesis of N-alkylamino- and 2,6-dideoxy-2-aminoglycoside lignan variants related to podophyllotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Clinical and pharmacokinetic study of oral NK611, a new podophyllotoxin derivative.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Antitumor agents, 107. New cytotoxic 4-alkylamino analogues of 4'-demethyl-epipodophyllotoxin as inhibitors of human DNA topoisomerase II

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Antitumor agents. 111. New 4-hydroxylated and 4-halogenated anilino derivatives of 4'-demethylepipodophyllotoxin as potent inhibitors of human DNA topoisomerase II.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Antitumor agents. 113. New 4 beta-arylamino derivatives of 4'-O-demethylepipodophyllotoxin and related compounds as potent inhibitors of human DNA topoisomerase II

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Antitumor agents. 148. Synthesis and biological evaluation of novel 4 beta-amino derivatives of etoposide with better pharmacological profiles

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Antitumor agents. 164. Podophenazine, 2'',3''-dichloropodophenazine, benzopodophenazine, and their 4 beta-p-nitroaniline derivatives as novel DNA topoisomerase II inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Dual inhibition of topoisomerase II and tubulin polymerization by azatoxin, a novel cytotoxic agent.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Cellular pharmacology of azatoxins (topoisomerase-II and tubulin inhibitors) in P-glycoprotein-positive and -negative cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Antitumor agents. 3. Synthesis and biological activity of 4 beta-alkyl derivatives containing hydroxy, amino, and amido groups of 4'-O-demethyl-4-desoxypodophyllotoxin as antitumor agents

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Methyl Ethers of Podophyllotoxin-Related Cyclolignans

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

Structure and mechanism of DNA topoisomerase II

1 reference

https://api.crossref.org/works/10.1016%2FS0300-9084%2898%2980004-7

7 January 2021

10.1016/S0300-9084(98)80004-7

Identifiers

DOI

1 reference

2 November 2017

1 reference